4//SEC Filing
Richard Robert E. 4
Accession 0000899243-23-003525
CIK 0001327273other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:41 PM ET
Size
7.7 KB
Accession
0000899243-23-003525
Insider Transaction Report
Form 4
Richard Robert E.
SVP of R&D
Transactions
- Award
Common Stock
2023-01-31+30,000→ 30,000 total - Award
Stock Option
2023-01-31+45,000→ 45,000 totalExercise: $2.85Exp: 2033-01-30→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in four (4) equal annual installments on the first four anniversaries of the grant date such that the RSUs will fully vest on January 31, 2027.
- [F2]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2023.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001816151
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:41 PM ET
- Size
- 7.7 KB